Hydrating Topical Foam
For Topical Dermatological Use Only
Caution: Federal Law restricts this product to sale by, or on the order of a licensed healthcare practitioner.
HYDRO 35 Foam is a keratolytic agent delivered in a water & lipid based emollient foam containing lactic acid. This foam gently softens excess tissue to enhance removal from skin and nails, while rehydrating healthy tissue. Each gram contains 35% Urea as the active ingredient.
Urea has the following chemical structure:
For enzymatic debridement and promotion of normal healing of surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris, or eschar. Topically applied urea is useful for the treatment of hyperkeratotic conditions such as dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, and dry, rough skin, as well as corns and calluses and damaged, ingrown and devitalized nails.
DOSAGE AND ADMINISTRATION
Apply to affected area twice a day unless otherwise directed by a prescribing healthcare practitioner. HYDRO 35 Foam should be rubbed gently into the skin until it is completely absorbed.
Follow these important directions to ensure proper foaming and maximum delivery of product:
- Shake canister vigorously before each use.
- Turn upside down (nozzle down) to dispense.
- Depress ridged portion of dispenser, as illustrated at right.
Urea 35%, dimethicone, ethylparaben, glycerin, lactic acid, methylparaben, phenoxyethanol, polysorbate 20, povidone, propylene glycol, propylparaben, purified water, stearic acid, trolamine, and as propellants isobutane and propane.
HYDRO 35 Foam is supplied in a 5.3 ounce (150g) pressurized canister bearing the NDC Number 23710-035-15 and in a 0.79 ounce (22g) pressurized canister bearing the NDC Number 23710-035-20.
Store at controlled room temperature 15° to 25°C (59° to 77°F).
Manufactured in the USA for: Quinnova Pharmaceuticals, LLC., Jamison, PA 18929. (877) 660-6263. www.QUINNOVA.com. Revised: December 2012
For external use only. Not for ophthalmic, oral, anal or intravaginal use. Avoid contact with the eyes, lips, and other mucous membranes.
KEEP THIS AND OTHER MEDICATIONS OUT OF THE REACH OF CHILDREN.
Contains flammable materials. Contents under pressure. Do not puncture or incinerate. Do not expose to temperatures over 120°F (48°C) even when empty.
Use only as directed by a healthcare practitioner. Do not use to treat any condition other than that for which it is prescribed. If redness or irritation occurs, discontinue use and contact the prescribing healthcare practitioner.
Animal reproduction studies have not been conducted with Hydro 35 Foam. It is also not known whether Hydro 35 Foam can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Hydro 35 Foam should be given to a pregnant woman only if clearly needed.
It is not known whether topically applied urea is excreted in human milk. Due to the fact that many drugs are excreted in human milk, caution should be exercised by physicians when administering HYDRO 35 Foam to nursing mothers.
No information provided.
HYDRO 35 Foam should not be used by persons who have a known hypersensitivity to urea or any of the listed ingredients.
Topically applied urea dissolves the intercellular matrix of the skin which results in softening of the hyperkeratotic tissue, and thus enhances shedding of scaly, dry skin. Urea topically applied to the nail plate has a similar effect on the intercellular matrix of the nail plate.
The mechanism of action of topical urea is not yet known.
No information provided. Please refer to the WARNINGS and PRECAUTIONS sections.
Skin Problems and Treatments Resources
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Health Solutions From Our Sponsors